Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02863055
Title Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma (NEMO)
Acronym NEMO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | GBR | BEL


No variant requirements are available.